Unicycive Therapeutics, Inc. Common Stock (NASDAQ: UNCY) last traded at $4.11, up 0.98% on the session. The quote above updates while this page is open; the figures below are drawn from Unicycive Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Unicycive Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker UNCY. Its market capitalisation is $114.49 million.
Valuation measures for Unicycive Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $114.49M |
|---|---|
| Enterprise value | $89.06M |
| Price / book | 2.15 |
| Beta | 0.98 |
Trailing-twelve-month figures tagged in Unicycive Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Net income (TTM) |
|---|
| -$35.22M |
| EPS (TTM) | -$1.25 |
|---|
| Return on equity | -66.12% |
|---|
| Cash | $44.19M |
|---|
Range and volume for UNCY over the past 52 weeks.
| 52-week high | $8.74 |
|---|---|
| 52-week low | $3.93 |
| Volume | 551.4K |
| Average volume | 834.9K |
| Previous close | $4.07 |
Invest a chosen dollar amount in Unicycive Therapeutics, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell UNCY.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.